In fact, by regulating PD-L1 expression, IGF2BP2 may contribute to immune evasion, further promoting tumour survival in the immune-suppressive microenvironment of pancreatic cancer [158]. Here, IGF2BP2 is linked to familial pancreatic carcinoma.